HMO and PPO Updates September Commercial Results

Similar documents
HMO and PPO Formulary Updates November Commercial Results

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

Save on your drugs with HealthyRx

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

P&T Committee Meeting Minutes (GHP Family Business) September 17, 2013

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Drug Formulary Update, October 2013

Pharmacy Policy Updates-Medicare Advantage

ANGIOTENSIN RECEPTOR BLOCKERS

2018 Step Therapy Criteria (List of Step Therapy Criteria)

ALLERGIC CONJUNCTIVITIS AGENTS

2014 Step Therapy Criteria (List of Step Therapy Criteria)

2018 Step Therapy Criteria (List of Step Therapy Criteria)

May 2017 P&T Updates

GHC-SCW Mandated Coverage Alphabetical Index Last Updated 8/1/2018

March 2018 P & T Updates

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

Victoza (Liraglutide) Solution for Injection

New Measure Recommended for Endorsement by PQA

Introducing exciting new Rx benefits 2019

Diabetes Medications: Oral Anti-Hyperglycemic Medications

ANTICONVULSANT STEP THERAPY

Additional drug coverage

Step Therapy Requirements. Effective: 12/01/2016

These medications will require preauthorization (PA) for HMSA Medicare Part D members.

Secretary for Health and Family Services Selections for Preferred Products

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

Additional DRUG COVERAGE

Drug Bill As Unit Common Directions Common Day Supply Common Billing Errors Oral Tablets/Capsules

2018 Step Therapy (ST) Criteria

Diseases & Conditions

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

Type II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements

Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)

Additional Drug Coverage

ANTIDIABETIC AGENTS - MISCELLANEOUS

Supplementary Online Content

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

Step Therapy Requirements. Effective: 1/1/2019

Pharmacy benefit guide

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 03/01/2015

Formulary Updates to DHMP Commercial Plans (POS/DMC/DMC-E/CSA/DERP/DPPA & DHMO:CSA/DERP/DPPA)

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017

Cash Wise Pharmacy $4 GENERIC MEDICATION FORMULARY. Cash Wise Pharmacy s $4 generic medication formulary is sorted by medical condition.

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ANTIDIABETIC AGENTS - MISCELLANEOUS

2013 Step Therapy (ST) Criteria

AETNA BETTER HEALTH January 2017 Formulary Change(s)

2014 Medicare Part D Formulary Formulary Additions

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

July 2017 P&T Updates

Uniform Formulary Decisions 9 January 2014

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014

Step Therapy Requirements. Effective: 05/01/2018

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

May 2016 P & T Updates

ANTICONVULSANTS. Details

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

Glucagon-Like Peptide (GLP-1) Receptor Agonists Clinical Edit Criteria

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Partners Notice of Change March 2017

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

ANTICONVULSANTS. Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

March 2017 P&T Updates

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

2014 Quantity Limits (QL) Criteria

ALLERGIC RHINITIS-NASAL

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

FirstCarolinaCare Insurance Company Step Therapy Requirements

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Drug Formulary Update, April 2013

Oral and Injectable Medication Options for Diabetes Treatment

II. UF CLASS REVIEWS SHORT-ACTING BETA AGONISTS (SABAs)

Pravastatin conversion to atorvastatin

Cardiovascular Drugs and Therapies HMG CoA a REDUCTASE INHIBITORS (available in Canada)

Professionalism & Service with Great Prices

Medication Policy Manual. Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013

Transcription:

HMO and PPO Updates September 2013- Commercial Results Triple Tier Formular y 4th Tier Applicable Traditiona l Quantit y Limit Alternatives SIRTURO 3 2 First fill: 56 tablets Subsequent fills: 24 tablets amoxicillin-clavulanic acid, clarithromycin, ethambutol, isoniazid, levofloxacin, pyrazinamide, rifampin, Avelox SUCLEAR 3 No 2 No No N/A Peg-3350 with electrolytes, Peg- 3350 with flavor packs, HalfLytely and Bisacodyl, GoLYTELY, MoviPrep, Prepopik OSPHENA 3 No 2 1 tablet per day Estring, Premarin Cream, Estrace Cream, Vagifem MEKINIST 3 2 tablets per 30 0.5 mg: 90 tablets per 30 e

HMO and PPO Updates September 2013- Commercial Results Triple Tier Formular y 4th Tier Applicable Traditiona l Quantit y Limit Alternatives INVOKANA 3 No 2 1 tablet per day chlorpropamide, glimepiride, glipizide IR, glipizide XL, glipizide-metformin, glyburide, glyburide micronized, metformin, pioglitazone, pioglitazoneglimepiride, pioglitazonemetformin, Januvia*, Janumet* DICLEGIS 3 No 2 4 tablets per day e LIPTRUZET 3 No 2 No N/A SIMBRINZA 3 No 2 No No N/A atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, Zetia brimonidine, dorzolamide, Azopt TECFIDERA 3 2 240 mg: 60 capsules per 30 120 mg: 14 capsules per 14 Starter Pack: 60 capsules per 30 Copaxone, Betaseron

HMO and PPO Updates September 2013- Commercial Results Triple Tier Traditiona 4th Tier Quantit Formular l Applicable y Limit Alternatives y EXJADE 3 2 No N/A e TAFINLAR 3 2 75 mg: 120 capsules per 30 50 mg: 120 capsules per 30 Zelboraf*

September 2013- CHIP Results Tier SIRTURO 3 Quantity Limit SUCLEAR 3 No No N/A First fill: 56 tablets Subsequent fills: 24 tablets OSPHENA 3 1 tablet per day 1 mg & 2 mg: 30 tablets per 30 0.5 mg: 90 tablets MEKINIST 3 per 30 Alternatives amoxicillin-clavulanic acid, clarithromycin, ethambutol, isoniazid, levofloxacin, pyrazinamide, rifampin, Avelox Peg-3350 with electrolytes, Peg-3350 with flavor packs, HalfLytely and Bisacodyl, GoLYTELY, MoviPrep, Prepopik Estring, Premarin Cream, Estrace Cream, Vagifem e INVOKANA 3 1 tablet per day chlorpropamide, glimepiride, glipizide IR, glipizide XL, glipizidemetformin, glyburide, glyburide micronized, metformin, pioglitazone, pioglitazone-glimepiride, pioglitazone-metformin, tolazamide, tolbutamide, Januvia*, Janumet* DICLEGIS 3 4 tablets per day e

September 2013- CHIP Results Tier Quantity Limit LIPTRUZET 3 No N/A SIMBRINZA 3 No No N/A Alternatives atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, Zetia brimonidine, dorzolamide, Azopt TECFIDERA 3 240 mg: 60 capsules per 30 120 mg: 14 capsules per 14 Starter Pack: 60 capsules per 30 Copaxone, Betaseron EXJADE 3 No N/A e TAFINLAR 3 75 mg: 120 capsules per 30 50 mg: 120 capsules per 30 Zelboraf*

GHP Family Member Updates September 2013- GHP Family Results GHP Family Tier Quantit y Limit Detailed Limits Alternative(s) SIRTURO 56 tablets for first fill, 24 tablets for subsequent fills. amoxicillin-clavulanic acid, clarithromycin, ethambutol, isoniazid, levofloxacin, pyrazinamide, rifampin, Zyvox (requires prior authorization) SUCLEAR PEG -3350 /na,sulf, bicarb, cl/kcl; polyethylene glycol 3350; sodium chlride, nahco3, kcl/peg OSPHENA 1 tabalet per day Premarin Cream MEKINIST Brand 1 mg and 2 mg tablets 30 tablets per 30, 0.5 mg 90 tablets per 30 glimepiride, glipizide, glipizide XL, glyburide, metformin, pioglitazone* INVOKANA 1 tablet daily *requires step therapy

GHP Family Member Updates September 2013- GHP Family Results DICLEGIS LIPTRUZET GHP Family Tier SIMBRINZA No Quantit y Limit Detailed Limits 4 tablets per day Alternative(s) atorvastatin, lovastatin, pravastatn, simvastatin, Zetia brimonidine, dorzolamide TECFIDERA TAFINLAR Brand 240 mg capsules - 60 capsules per 30, 120 mg capsules - 14 capsules per 7, starter pack - 60 capsules per 30 120 capsules per 30 Avonex*, Betaseron, Copaxone, Gilenya*, Rebif* Zelboraf*

GOLD Member Updates September 2013- Part D (Gold) Updates SIRTURO SUCLEAR OSPHENA $0 Deductible Brand Preferred MEKINIST Speciality Standard coinsurance No coinsurance 2013 No Quantity Limit g g 30 tablets per 30 ; 0.5mg: 90 tablets per 30 Alternative(s) Amoxicillin-clavulanic acid, clarithromycin, ethambutol, isoniazid, levofloxacin, pyrazinamide, rifampin, Avelox, Zyvox* - *prior authorization required Peg-3350 with Electrolytes, Peg-3350 with flavor packets, GoLYTELY, MoviPrep, OsmoPrep, Prepopik Premarin Cream, Estrace Cream, Estring, Vagifem Zelboraf* *prior authorization required

GOLD Member Updates September 2013- Part D (Gold) Updates $0 Deductible Standard 2013 Quantity Limit Alternative(s) INVOKANA DICLEGIS LIPTRUZET SIMBRINZA Brand Preferred Brand Preferred Brand Preferred coinsurance coinsurance coinsurance No No 1 tablet per day 4 tablets per day Generics : chlorpropamide, glimepiride, glipizide IR, glipizide XL, glipizidemetformin, glyburide, glyburide micronized, metformin, pioglitazone, pioglitazone-glimepiride, pioglitazone-metformin, tolazamide, tolbutamide. e atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, Crestor, Zetia brimonidine, dorzolamide, Azopt TECFIDERA TAFINLAR Speciality coinsurance 75mg and 50mg: 120 capsules per 30 Aubagio*, Avenox*, Betaseron, Copaxone, Tysabri* *prior authorization required Zelboraf* *prior authorization required